Lisata Therapeutics Deal History & Licensing Activity
Lisata Therapeutics is a biotech headquartered in US. Over the past three years, Lisata Therapeutics has been involved in 3 licensing and acquisition transactions, with a primary focus on Other (2 deals).
Deals (12mo)
2
Active Trials
1
Top Modality
Other
Focus Area
Metabolic
Lisata Therapeutics Recent Deal Activity
Licensing, acquisition, and partnership transactions involving Lisata Therapeutics in the past 12 months.
| Asset | Partner | Modality | Phase | Type | Date |
|---|---|---|---|---|---|
| MAR001/005 (severe hypertriglyceridemia) and MAR002 (acromegaly) | Marea Therapeutics | Other | Phase 2 | acquisition | Sep 17, 2026 |
Lisata Therapeutics Pipeline Focus
Therapeutic areas and modalities where Lisata Therapeutics is most active based on deal history and clinical trial data.
See How Your Asset Matches Lisata Therapeutics's Portfolio
Use Solidus to benchmark upfront payments, milestones, and royalties for Metabolic assets — powered by data from 3,500+ real biopharma transactions.
Related Intelligence
Metabolic Deal Benchmarks
Market sizing, deal terms, and competitive landscape for metabolic
Oncology Deal Benchmarks
Market sizing, deal terms, and competitive landscape for oncology
Other Benchmarks
Upfront, milestone, and royalty benchmarks for other deals
Peptides Benchmarks
Upfront, milestone, and royalty benchmarks for peptides deals
Deal Pulse
Track the latest biopharma licensing and acquisition deals across all therapeutic areas
All Company Profiles
Browse 700+ biotech and pharma company profiles with deal history and pipeline data
2026 Deal Benchmarks Report
Industry-wide analysis of deal terms, trends, and market dynamics
About Lisata Therapeutics Licensing & Deal Activity
Lisata Therapeutics is a biotech company based in US that has been actively engaged in licensing transactions across the biopharma landscape. With 3 deals over the past three years, Lisata Therapeutics ranks among the actively acquisitive companies tracked by Ambrosia Ventures.
Key therapeutic areas of focus for Lisata Therapeutics include Metabolic (2 deals and trials), Oncology (1 deal and trial), and Other (1 deal and trial). In terms of modality, Lisata Therapeutics has shown particular interest in other, peptides.
Ambrosia Ventures tracks deal terms, pipeline data, patent expirations, and competitive positioning for Lisata Therapeutics and 700+ other biopharma companies. Use our Solidus to benchmark your asset against Lisata Therapeutics's historical deal terms, or explore all company profiles to find the best partner match for your pipeline.